Self-Referential Large Models: Recursive Self-Enhancement in Code Generation ...

Adding a bullish note to Ethereum’s broader ecosystem, recently, Buterin also endorsed Codex, a stablecoin-focused Layer 2 ...

Alibaba research scientist Binyuan Hui says large language models (LLMs) will soon surpass humans in coding. He argues that ...

Recursion will also receive an additional $30 million upfront payment from Bayer to develop new treatments for chronic scar tissue, or fibrotic, diseases of the lung, kidneys and heart.

Recursion Pharmaceuticals (RXRX) reported significant growth in sales and revenue for Q2 and the first half of 2025 but also experienced widening net losses. The release of their Boltz-2 model ...

Recursion Pharmaceuticals dropped for a third straight day on Wednesday, slashing 6.29 percent to close at $4.77 apiece after investors mimicked the recent selling of three company executives.

According to data compiled by S&P Global Market Intelligence, Recursion Pharmaceuticals (RXRX -3.49%) stock was shedding more than 17% of its value week-to-date as of Thursday night.

Explore RXRX's upcoming H2'25 trial updates for REC-4881 in familial adenomatous polyposis and REC-617.

CISA urges federal agencies to immediately patch an exploited arbitrary file write vulnerability in Git that leads to remote ...